Clik here to view.
Pioneer Liability and the Wyeth Case
Attorneys, politicians, legal scholars, and, of course, pharmaceutical executives have called the judgment “unprecedented” and “dangerous” – even “absurd. On November 7, 2008, a California appellate...
View ArticleClik here to view.
Access to Antiretrovirals in Latin America
The average new drug takes $1.3 billion and 10-15 years to develop, with only two out of ten marketed drugs ever producing revenues that match R&D costs. From 2003 to 2005 alone, the number of...
View ArticleClik here to view.
Drug Production: Public Interest vs. Intellectual Property Rights
In light of the current costs of developing a drug, companies have no incentive to produce medications that treat diseases in areas of minimal buying power. The struggle between the public and Big...
View ArticleClik here to view.
Pharmaceutical Companies and the Future of Medicine
When Merck & Co. put $145 million into advertising the drug Vioxx, sales of the drug rose by an astounding $1.5 billion. Recent pharmaceutical industry statistics are staggering. According to the...
View ArticleClik here to view.
The Rise of Consumer Directed Advertising
Over the past quarter-century, prescription drug manufacturers in the United States have increasingly invested in direct-to-consumer advertising (DTCA) designed to build brand recognition and foster...
View ArticleClik here to view.
Compassionate Drug Use
“I take risks, sometimes patients die, but not taking risks causes more patients to die—so I guess my biggest problem is I've been cursed with the ability to do the math.” – Dr. House At first glance,...
View ArticleClik here to view.
Essential Medicines: The Crisis in Developing Countries
High costs force developing nations to devote most of their resources simply to the attainment of medicine, money which in developed nations is employed toward better technology and more advanced...
View ArticleClik here to view.
The Growth of International Pharmaceuticals
This potential to create solutions to global health through sustainable entrepreneurship provides a much-needed response to previously ignored diseases. A new drug to treat HIV is set to be...
View ArticleClik here to view.
The FDA and Weight-Loss Drugs: Ensuring Consumer Freedom while Emphasizing...
Given the CDC estimate that over one-third of the U.S. adult population is obese, the availability of weight-loss drugs has been a controversial topic. According to the Mayo Clinic, weight-loss drugs...
View ArticleDrug Discovery and Research Institutions
Over the past half century, drug discovery within the research realm has greatly advanced with the advent of rapidly developing technology, and has to date been responsible for saving countless lives....
View Article
